Atelerix enters agreement with Cherry Biotech to integrate non-cryogenic transport solutions with advanced organoid models

Atelerix enters agreement with Cherry Biotech to integrate non-cryogenic transport solutions with advanced organoid models

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has entered a partnership with Cherry Biotech, a French company specializing in organ-on-chip and organoid technologies for biomedical research.

Atelerix Inks Advanced Organoid Model Deal with Cherry Biotech

Atelerix, a biotech company working on cell preservation and biological transport with its hydrogel encapsulation technology, entered a partnership with Cherry Biotech, a French company specializing in organ-on-chip and organoid technologies. The initial agreement will explore the integration of Atelerix’s hydrogel technology with Cherry Biotech’s advanced 3D organoid models to facilitate global extended-duration shipment. In collaboration, the …

Atelerix enters agreement with Cherry Biotech

Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, has entered a partnership with Cherry Biotech.